Scalar Market Research

Diabetes Care Devices Market Is Expected to Reach USD 26.94 Billion by 2022 - Scalar Market Research

The global diabetes care devices market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the diabetes care devices market.


Chicago, IL -- (SBWIRE) -- 02/27/2017 -- According to the report, "Diabetes Care Devices Market, by Products (Insulin Delivery Devices, Diabetes Monitoring Devices, Diabetes Care Solutions), Geography (North America, Europe, Asia-Pacific, Rest of the World) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", the market for diabetes care devices market is expected to grow at a steady rate during the forecast period, due to the rising demand from the developing regions.

Download Free Sample :

Buyers Can Get 10% on Customization on This Report.

The diabetes care devices market report offers details about the growth trends and revenue forecasts for the global market. It also provides the information about the key market players, drivers, restraints, segmentation, and market share.

According to the diabetes care devices market report, the global market is set to grow at a healthy CAGR during the forecast period. The report attributes this growth of the market to the rising instances of diabetes across the world. According to the report, the factors such as obesity, changing lifestyles, and dietary changes are some of the contributing factors to the growing instances of diabetes. The report also observes a strong rise in demand across the emerging markets including Asia-Pacific and Latin America. As a result, the report predicts a strong rise in demand for the diabetes care devices from these geographic regions. The rising awareness towards early detection of the disease is also a significant driving factor for this market, on a global scale.

The diabetes care devices market report segments the global market by products and geographic regions. The report segments the types of products into diabetes monitoring, insulin delivery devices, and diabetes care solutions. The major geographic regions include Asia-Pacific, North America, Europe, and the Rest of the World. According to the report, North America is set to dominate the global market based on the overall market share. Asia-Pacific, on the other hand, is expected to witness the fastest growth rate during the forecast period. The changing lifestyles and the population growth are some of the major driving factors for the growth of the market in the Asia-Pacific region.

The key players included in the diabetes care devices market report include:

1. Abbott Laboratories,
2. ARKRAY, Inc.,
3. Bayer HealthCare AG,
4. Becton Dickinson and Company,
5. Eli Lilly and Company,
6. F. Hoffmann-La Roche AG,
7. Johnson & Johnson,
8. Medtronic, Inc.,
9. Novo Nordisk A/S, Sanofi S.A,
10. Tandem Diabetes Care, Inc.,
11. Terumo Corporation,
12. Ypsomed AG,

The report predicts impressive growth for the key market players, due to the rising prevalence of diabetes across the developing markets.

Related Reports:

Prescription Pharmaceuticals Market to reach USD 918.74 billion by 2020.

Home Healthcare Market expected to reach USD 257.34 billion by 2021

Dermatology Devices Market is expected to reach USD 16.05 billion by 2022

About Scalar Market Research
Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at:

Mr. Moses Nakka,
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: 800-213-5170 (U.S./Canada Toll-free)